Teva stock jumps toward longest win streak in 2 years, after Bernstein analyst turns bullishMarket Watch • 03/25/22
Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S.Business Wire • 03/07/22
Teva Canada Welcomes Public Drug Plan Reimbursement by Alberta, Saskatchewan, Québec, Veteran Affairs Canada and the Non-Insured Health Benefits Program for Patients prescribed AJOVY® (fremanezumab) for the Preventive Treatment of Migraine in AdultsBusiness Wire • 03/02/22
Bleichmar Fonti & Auld LLP Announce a Proposed Class Action Settlement Involving Purchasers of Teva Pharmaceutical SecuritiesPRNewsWire • 02/21/22
Teva Pharmaceutical Industries Ltd. (TEVA) CEO Kåre Schultz on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/09/22
Teva stock falls after revenue falls below expectations, full-year profit outlook missesMarket Watch • 02/09/22
Teva Reaches Agreement With Texas to Settle the State's Opioid-Related ClaimsBusiness Wire • 02/07/22
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial Guidance at 8 a.m. ET on February 9, 2022Business Wire • 01/18/22